Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F20%3A10410843" target="_blank" >RIV/00216208:11130/20:10410843 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216224:14110/20:00115435 RIV/00159816:_____/20:00072883 RIV/00064203:_____/20:10410843

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=eB1PtHJyBB" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=eB1PtHJyBB</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.jaip.2019.08.011" target="_blank" >10.1016/j.jaip.2019.08.011</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Popis výsledku v původním jazyce

Hereditary angioedema (HAE), an inherited deficiency of functional C1 esterase inhibitor (C1-INH), is characterized by recurrent episodes of disabling and often painful swelling in subcutaneous and/or submucosal tissues.1 HAE attacks are generally unpredictable, but triggers for an attack can include having a dental or medical procedure (eg, surgery), other trauma, or stress. A preemptive management plan for patients undergoing these types of situations may reduce the risk of HAE attacks.2 Recommendations include administration of short-term prophylaxis in patients with HAE before invasive medical procedures, especially those involving the upper airways or digestive tract, with C1-INH concentrate typically the medication of choice.

Název v anglickém jazyce

Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Popis výsledku anglicky

Hereditary angioedema (HAE), an inherited deficiency of functional C1 esterase inhibitor (C1-INH), is characterized by recurrent episodes of disabling and often painful swelling in subcutaneous and/or submucosal tissues.1 HAE attacks are generally unpredictable, but triggers for an attack can include having a dental or medical procedure (eg, surgery), other trauma, or stress. A preemptive management plan for patients undergoing these types of situations may reduce the risk of HAE attacks.2 Recommendations include administration of short-term prophylaxis in patients with HAE before invasive medical procedures, especially those involving the upper airways or digestive tract, with C1-INH concentrate typically the medication of choice.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30102 - Immunology

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2020

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Allergy and Clinical Immunology. In Practice

ISSN

2213-2198

e-ISSN

—

Svazek periodika

8

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

4

Strana od-do

799-802

Kód UT WoS článku

000512964500062

EID výsledku v databázi Scopus

2-s2.0-85071864411